Literature DB >> 24198066

Insights into thymic involution in tumor-bearing mice.

Roberto Carrio1, Diana M Lopez.   

Abstract

The thymus is a central lymphoid organ critical for the development and maintenance of an effective peripheral T-cell repertoire. Most important, it provides a specialized environment for the selection of rearranged clones that will function appropriately in the adaptive immune response. Thymic involution has been observed in several model systems; including graft-versus-host disease, aging, viral infection, and tumor development, however, the precise mechanisms involved in this phenomenon remain poorly defined. Here, we review some of our results related to the studies of the cell-mediated immunity in a mammary tumor model; more specifically, those related to the tumor-induced impaired T-cell development and thymic involution. Collectively, the understanding of the mechanisms and pathways associated with the tumor-induced thymic involution is essential for the development of innovative and safe therapies to fight against the immune suppression caused by the tumor development.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24198066     DOI: 10.1007/s12026-013-8446-3

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  75 in total

1.  Tumor-induced thymic atrophy: alteration in interferons and Jak/Stats signaling pathways.

Authors:  Roberto Carrio; Marta Torroella-Kouri; Vijaya Iragavarapu-Charyulu; Diana M Lopez
Journal:  Int J Oncol       Date:  2010-12-14       Impact factor: 5.650

Review 2.  BCL-2 family: regulators of cell death.

Authors:  D T Chao; S J Korsmeyer
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

3.  BCL-XL-regulated apoptosis in T cell development.

Authors:  D T Chao; S J Korsmeyer
Journal:  Int Immunol       Date:  1997-09       Impact factor: 4.823

4.  T-cell recruitment from the thymus to the spleen in tumor bearing mice: phenotypical alteration and recruitment of thymocytes raised in a tumor bearing state.

Authors:  K Tanaka; Y Koga; K Taniguchi; K Nomoto
Journal:  Cancer Res       Date:  1987-04-15       Impact factor: 12.701

5.  Thymus-derived glucocorticoids regulate antigen-specific positive selection.

Authors:  M S Vacchio; J D Ashwell
Journal:  J Exp Med       Date:  1997-06-02       Impact factor: 14.307

6.  Thymic atrophy induced by murine mammary adenocarcinoma in vivo.

Authors:  Y X Fu; N Altman; D M Lopez
Journal:  In Vivo       Date:  1989 Jan-Feb       Impact factor: 2.155

7.  bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death.

Authors:  L H Boise; M González-García; C E Postema; L Ding; T Lindsten; L A Turka; X Mao; G Nuñez; C B Thompson
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

8.  Downregulation of interleukin-7 and hepatocyte growth factor in the thymic microenvironment is associated with thymus involution in tumor-bearing mice.

Authors:  Roberto Carrio; Norman H Altman; Diana M Lopez
Journal:  Cancer Immunol Immunother       Date:  2009-05-07       Impact factor: 6.968

Review 9.  Growth factors, cytokines and soluble forms of receptor molecules in cancer patients.

Authors:  W Zumkeller; P N Schofield
Journal:  Anticancer Res       Date:  1995 Mar-Apr       Impact factor: 2.480

Review 10.  The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis.

Authors:  R Zarnegar; G K Michalopoulos
Journal:  J Cell Biol       Date:  1995-06       Impact factor: 10.539

View more
  3 in total

1.  Establishment of a mouse model of cancer cachexia with spleen deficiency syndrome and the effects of atractylenolide I.

Authors:  Wan-Li Zhang; Na Li; Qiang Shen; Men Fan; Xiao-Dong Guo; Xiong-Wen Zhang; Zhou Zhang; Xuan Liu
Journal:  Acta Pharmacol Sin       Date:  2019-07-24       Impact factor: 6.150

2.  The Attenuated Live Yellow Fever Virus 17D Infects the Thymus and Induces Thymic Transcriptional Modifications of Immunomodulatory Genes in C57BL/6 and BALB/C Mice.

Authors:  Breno Luiz Melo-Lima; Danillo Lucas Alves Espósito; Benedito Antônio Lopes da Fonseca; Luiz Tadeu Moraes Figueiredo; Philippe Moreau; Eduardo Antonio Donadi
Journal:  Autoimmune Dis       Date:  2015-09-17

3.  Antitumor Efficacy and Mechanism in Hepatoma H22-Bearing Mice of Brucea javanica Oil.

Authors:  Wen-Rong Shi; Yan Liu; Xiao-Ting Wang; Qiong-Ying Huang; Xue-Rong Cai; Shao-Rong Wu
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-05       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.